As of March, 11 Rexahn Pharmaceuticals, Inc. (RNN) EPS Estimated At $-0.13 – The EN Bulletin

As of March, 11 Rexahn Pharmaceuticals, Inc. (RNN) EPS Estimated At $-0.13 The EN Bulletin

Rexahn Pharmaceuticals, Inc. (NYSEAMERICAN:RNN) is anticipated to announce earnings on March, 11., according to Faxor. Analysts forecast $-0.13 EPS, …